Project archive

Fraunhofer ITEM is one of four partners in this project that was initiated by the German Centre for Rail Traffic Research (DZSF). We will be contributing to the following project goals, among others.

As part of the Mono4ERA Project, the European Comission conduct a Feasibility study of an active-substance-based review system (“monographs”) and other potential alternatives for the environmental risk assessment of veterinary medicinal products.

Fraunhofer ITEM is actively involved in the search for new active substances for COVID-19 treatment. For these studies, conducted in cooperation with universities and other institutes, PCLS are prepared from human lung tissue and infected with SARS-CoV-2 in an appropriate laboratory.

Fraunhofer researchers have developed the intuitive, web-based end-to-end pipeline MyDeepLearn. MyDeepLearn links the CNNs in the back end with the web application in the front end.

A bronchoscope is used to apply LPS segmentally in the lungs. Using this provocation model, the researchers investigated the effect of a bradykinin-1 receptor antagonist.

Researchers at Fraunhofer ITEM have significantly developed a model of allergen provocation using allergen solutions.

Fraunhofer vs. Corona: as an institute with decades of experience in infection and airway research, drug development, biomedical engineering, and in the field of chemical risk assessment, Fraunhofer ITEM can make an important contribution to scientific progress in the fight against the new coronavirus.

Fraunhofer researchers have been investigating a spray product for room conditioning in hairdressing salons.

Researchers participating in the RNA Therapeutics platform by the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD are studying circRNAs in human cardiomyocytes from patients that have experienced a SARS-CoV-2 infection.

The FingerKIt consortium develops personalized joint implants using AI-based 3D printing.